Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston
Seqens Group opens the Seqens Boston R&D Center, a state-of-the-art, 15,000 square-foot R&D center in...
Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus Vaccine...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced mRNA-1345, an investigational...
Lilly Plans to Invest Additional $450 million at Manufacturing Site in Research Triangle Park
Eli Lilly and Company announced plans to invest an additional $450 million and create at...
SK bioscience introduces new partnership model to establish regional vaccine hubs
SK bioscience, a global innovative vaccine and biotech company, introduced a new global partnership model...
Catalent Completes Commercial-Scale Plasmid DNA Manufacturing Facility in Gosselies, Belgium
Catalent, the leader in enabling the development and supply of better treatments for patients worldwide,...
Zennova Pharmaceuticals Opens Manufacturing and R&D Center in China
Zennova Pharmaceuticals, a Princeton, NJ-based development stage pharmaceutical company focused on complex ophthalmic suspensions and...
PIK-75 May End Up Being A Saviour Drug For Acute Leukaemia
National University of Singapore researchers have gone ahead and revisited a drug which they believe...
A Biosimilars Pilot Program Is In The Offering By The FDA
The FDA has gone on to release the Biosimilar User Fee Amendments III Regulatory Science...
Making Immunotherapy Work In The Tumour Microenvironment
One of the latest studies that takes into account the tumour microenvironment of pancreatic cancer...
UK All Set For New Drug Manufacturing Regulatory Framework
As UK will introduce a customised framework for the innovative medicines’ regulation manufactured at the...
